Navigation Links
Cancer and arthritis therapy may be promising treatment for diabetes
Date:12/18/2007

New Haven, Conn.An antibody used to treat certain cancers and rheumatoid arthritis appears to greatly delay type 1 diabetes in mice, Yale School of Medicine researchers report in the Journal of Clinical Investigation.

Even better, the beneficial effects of the antibody continue to be observed long after the antibody is no longer administered, the researchers said.

The antibody, rituximab (anti-CD20), depletes B cells. Experimental evidence in mutant mice indicates that B cells play a role in autoimmune diseases by interacting with T cells of the immune system. It is T cells that destroy insulin-producing cells directly in the pancreas, leading to type 1 diabetes.

Our paper shows, for the first time, that after successful B cell depletion, regulatory cells emerge that can continue to suppress the inflammatory and autoimmune response even after the B cells return, said Li Wen, senior research scientist in the division of endocrinology. Even more strikingly, we found that these regulatory cells include both B and T cells.

To determine if B cell depletion would work as a therapy for type 1 diabetes, Wen and her colleague at Yale, Mark Shlomchik, M.D., professor of laboratory medicine and immunobiology, developed a mouse model. They engineered mice that were predisposed to diabetes and had the human version of CD20, the molecule rituximab targets, on the surface of their B cells.

The researchers tested a mouse version of the drug to deplete B cells in mice either before diabetes onset, or within days of diagnosis with diabetes. The drug treatment significantly delayed diabetes onset in pre-diabetic mice. This translated to a 10- to 15-week delay in developing diabetes compared to mice given a sham treatment. The equivalent period for humans would be approximately 10 to 15 years. Of the 14 mice that already had diabetes, five stopped needing insulin for two to five months while all the sham-treated mice remained dia
'/>"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. ESF EURYI award winner aims to stop cancer cells reading their own DNA
4. Protein chatter linked to cancer activation
5. Newly created cancer stem cells could aid breast cancer research
6. Western diet linked to increased risk of colon cancer recurrence
7. Obesity and lack of exercise could enhance the risk of pancreatic cancer
8. Low levels of key protein may indicate pancreatic cancer risk
9. Birth records hold pancreatic cancer clue
10. Many parents at-risk for cancer disclose genetic test results to children
11. A new radiation therapy treatment developed for head and neck cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...bacteria, it turns out, hold the power to help mil...the world clean up toxic waste on test sites. , ...ere invented back in World War II and have been us...energy compounds are often used to propel tank she... , But with increased knowledge of their environ...
(Date:11/4/2009)...f., Oct. 20 DigitalPersona, Inc., ...n solutions, today announced that WAND Corporation...re for quick-service restaurants, has integrated D...d Classic POS solutions. WAND,s quick-service cust...cashier accountability and deter unauthorized mana...
(Date:11/4/2009)... Global Rainmakers, Inc., an intell...;D laboratory, today announced that the company ha...ively commercialize its suite of technologies desi...fferings. ,, During the past four years, the co...elop and deploy a series of core--but expandable--...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 1BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 2BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 4BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 5BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 6BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 7Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 1Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 2Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 3Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 4Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium 60440 5Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 1Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 2
...ocess for common ear infections will be the focus ...Hearing Institute (LEHI). , The research will aim ... (and why some do not heal at all) by identifying ...process of an infected human ear drum. , Accordin... the world,s population suffers from ,chronic otit...
...rs of Health in Africa declared that a dramatic ri...ncy. In some African countries, annual TB case not...r the past 15 years. The main culprit? The emergen... HIV and TB, they are more likely to progress from...e problem, the World Health Organization currently...
...eing discovered in the Southeast Asia nation of La...onservation Society, which says that six new frog ...ear period. , Working in conjunction with the WCS...e species in the recent issue of Copeia, the journ...chthyologists. Little is known about the new frog...
Other Biology News:World first research to speed up cure for ear infections 2Laos ?a lost world for frogs 2
(Date:11/5/2009)...OMAHA, Neb., Nov. 5 Tran...nounced financial results for the quarter ended Se...are presented in the tables that follow. ,, Th... loss of $366,000 or $0.01 per share for the third...,000 or $0.01 per share for the third quarter of 2...
(Date:11/5/2009)...SUNNYVALE, Calif., Nov. 5 /PRNewswire-FirstCall/ -...s executives will be speaking at the following inv...ipate via webcast. , , Credit Suis... Thursday, 12 November, 2009 at 10 a.m. Mounta... Program, London, England, Tuesday...
(Date:11/5/2009)...SAN DIEGO, CA, November 5, 2009 /PRNewswire-FirstC...focused on using proprietary taste receptor-based ...for the food, beverage, and ingredient supply indu...rted financial results for the third quarter ended...or the third quarter of 2009, compared to $4.0 mil...
(Date:11/5/2009)...AUSTIN, Texas, Nov. 5 SpineSmith P...teo, Inc. to co-develop a unique scaffold that mim...lowing evaluation of several commercial products b..., the company believes the GenOsteo scaffold repre... creates a unique and ideal environment for the de...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...N.Y., April 9, 2008 Genetic Engineering,and Biote...ill present a podcast,with Robert Langer, Ph.D., o..., April 10, 2008, 4 p.m. EDT, Dr. Langer is insti...g,Massachusetts Institute of Technology. "Robert L...ern drug delivery," says John Sterling,Editor-in-C...
...ction market to grow over 23% per year due to new ...llennium Research Group, WALTHAM, Mass., April 9,...RG) US Markets for Body Contouring Devices 2008 re...th almost $80 million in 2007,and will see conside...ver,$215 million by 2012. Growth will be attribute...
..., April 9, 2008 Cardiac Science,Corporation (Nasd...iagnosis,resuscitation, rehabilitation, and inform...act from the Australian Defence Force for the init...d external defibrillators (AEDs) and,accessories. ...cluding a,100-unit delivery to Eastern European mi...
Other Biology Technology:Genetic Engineering and Biotechnology News (GEN) Presents Exclusive Podcast with Robert Langer, Ph.D. on New Polymeric Drug Delivery Systems 2Say Good-Bye to Cellulite 2Australia Chooses Cardiac Science to Equip Its Defence Force 2Australia Chooses Cardiac Science to Equip Its Defence Force 3
...d Separation is a powerful tool for sample purific... Typical applications are DNA/RNA or protein purif... fully automated on the Genesis Series of instrume...mbination with the RoMa arm and Tecans powerful FA...
... Collection of Cell Cultures (ECACC) has been offe...emia and government institutes for over seven year... candidates to cell culture and a Level II course ...nning and management of a cell culture laboratory,...
... filters suitable for use in the Microsart e.motio...top of each filter, in a specially designed indivi... the band of membrane filter units ensures that th... the sealed band guarantees uniform dispensing of ...
DU 530 Life Science UV/Visible Spectrophotometers from Beckman Coulter
Biology Products: